Skip to main content
SpringerLink
Log in

Therapeutisches Drug Monitoring

  • Chapter
  • First Online:
Therapie der Depression

  • 13k Accesses

Zusammenfassung

Nach einer kurzen Einführung in das therapeutische Drug Monitoring (TDM) wird die praktische Durchführung von TDM beschrieben. An Einzelfällen wird beispielhaft dargestellt, wie TDM für die Steuerung der antidepressiven Therapie sinnvoll genutzt werden kann. Es soll verdeutlicht werden, dass TDM ein Instrument der individualisierten Pharmakotherapie ist, ein Werkzeug für rationale Pharmakotherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Asberg M, Cronholm B, Sjöqvist F, Tuck D (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4(5726):18–21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Asberg M, Crönholm B, Sjöqvist F, Tuck D (1971) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3(5770):331–334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Adli M, Baethge C, Heinz A et al (2005) Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 255(6):387–400

    Article  PubMed  Google Scholar 

  • Baumann P, Hiemke C, Ulrich S et al (2004) The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243–265

    Article  CAS  PubMed  Google Scholar 

  • Bengtsson F (2004) Therapeutic drug monitoring of psychotropic drugs. TDM “nouveau”. Ther Drug Monit 26(2):145–151

    Article  PubMed  Google Scholar 

  • Bundesärztekammer (2014) Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen Deutsches Ärzteblatt 111: A1583-A1618 http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/Rili-BAEK-Laboratoriumsmedizin.pdf. Zugegriffen: 14. Apr 2016

  • Crettol S, de Leon J, Hiemke C, Eap CB (2014) Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine. Clin Pharmacol Ther 95(3):254–257

    Article  CAS  PubMed  Google Scholar 

  • Eap CB, Jaquenoud Sirot E, Baumann P (2004) Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies. Ther Drug Monit 26:152–155

    Article  CAS  PubMed  Google Scholar 

  • Haen E, Greiner C, Bader W, Wittmann M (2008) Wirkstoffkonzentrationsbestimmungen zur Therapieleitung. Ergänzung therapeutischer Referenzbereiche durch dosisbezogene Referenzbereiche. Nervenarzt 79(5):558–566

    Article  CAS  PubMed  Google Scholar 

  • Hiemke C, Eckermann G (2014) Kombinationstherapie/Polypharmazie: Interaktionen von Psychopharmaka. Psychopharmakotherapie 21:269–279

    Google Scholar 

  • Hiemke C, Dragicevic A, Kuss H-J et al (2005) TDM zur Optimierung der antidepressiven Pharmakotherapie. Med Welt 56:338–343

    Google Scholar 

  • Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G (2011) AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry 44(6):195–235

    Article  Google Scholar 

  • Isacsson G, Bergman U, Wasserman D et al (1996) The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 8(3):153–160

    Article  CAS  PubMed  Google Scholar 

  • Jaquenoud Sirot E, van der Velden JW, Rentsch K et al (2006) Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance. Drug Saf 29:735–768

    Article  PubMed  Google Scholar 

  • Johne A, Schmider J, Brockmöller J et al (2002) Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John’s wort (Hypericum perforatum). J Clin Psychopharmacol 22(1):46–54

    Article  CAS  PubMed  Google Scholar 

  • Kootstra-Ros JE, Van Weelden MJ, Hinrichs JW et al (2006) Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice. J Clin Pharmacol 46(11):1320–1327

    Article  CAS  PubMed  Google Scholar 

  • Lingam R, Scott J (2002) Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105(3):164–172

    Article  PubMed  Google Scholar 

  • Lundmark J, Bengtsson F, Nordin C et al (2000) Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatr Scand 101:354–359

    Article  CAS  PubMed  Google Scholar 

  • Mann K, Hiemke C, Schmidt LG, Bates DW (2006) Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care. Ther Drug Monit 28:83–88

    Article  PubMed  Google Scholar 

  • Müller MJ, Dragicevic A, Fric M et al (2003). Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Pharmacopsychiatry 36(3):98–104

    Article  PubMed  Google Scholar 

  • Ostad Haji E, Hiemke C, Pfuhlmann B (2012) Therapeutic drug monitoring for antidepressant drug treatment. Curr Pharm Des 18(36):5818–5827

    Article  PubMed  Google Scholar 

  • Ostad Haji E, Mann K, Dragicevic A et al (2013a) Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram. Ther Drug Monit 35(3):396–401

    Article  PubMed  Google Scholar 

  • Ostad Haji E, Tadic A, Wagner S et al (2013b) Early improvement and serum concentrations of citalopram to predict antidepressant drug response of patients with major depression. Pharmacopsychiatry 46(7):261–266

    Article  CAS  PubMed  Google Scholar 

  • Preskorn SH, Simpson S (1982) Tricyclic-antidepressant-induced delirium and plasma drug concentration. Am J Psychiatry 139(6):822–823

    Article  CAS  PubMed  Google Scholar 

  • Preskorn SH, Burke MJ, Fast GA (1993) Therapeutic drug monitoring. Principles and practice. Psychiatr Clin North Am 16(3):611–645

    CAS  PubMed  Google Scholar 

  • Simmons SA, Perry PJ, Rickert ED, Browne JL (1985) Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients. J Affect Disord 8:47–53

    Article  CAS  PubMed  Google Scholar 

  • Stamm TJ, Becker D, Sondergeld LM et al (2014) Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoring. Pharmacopsychiatry 47(4–5):174–179

    CAS  PubMed  Google Scholar 

  • Vuille F, Amey M, Baumann P (1991) Use of plasma level monitoring of antidepressants in clinical practice – towards an analysis of clinical utility. Pharmacopsychiatry 24:190–195

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Psychiatrie und Psychotherapie, Untere Zahlbacher Str.8, 55131, Mainz, Deutschland

    Christoph Hiemke

Authors
  1. Christoph Hiemke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Hiemke .

Editor information

Editors and Affiliations

  1. Zentrum für Psychosoziale Medizin, Agaplesion Diakonieklinikum Rotenburg, Rotenburg, Germany

    Carsten Konrad

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

1 Elektronische Zusatzmaterial

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Hiemke, C. (2017). Therapeutisches Drug Monitoring. In: Konrad, C. (eds) Therapie der Depression. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50347-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50347-8_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50346-1

  • Online ISBN: 978-3-662-50347-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation